Wednesday, February, 20, 2019 11:56:49

Contribution By Sunil Hebbalkar


Expert System and Rabobank to collaborate on cognitive AI platform

The artificial intelligence firm Expert System and Rabobank, a financial services company have reportedly entered into a partnership for leveraging the power of Expert Systems flagship platform, Cogito®. The platform is based on a unique blend of Artificial Intelligence (AI) technology and machine learning. Apparently, …

Amazon launches Audible in India, service still in beta stage

Recently Amazon announced the launching of its audiobook service Audible in India. The subscription-based service that has been much awaited in the country is the second to be launched by the online retail behemoth after it launched Prime. The Audible subscription is expected to complement …

U.S. FDA approves Pfizer Inc’s lung cancer medicine LORBRENA®

Pfizer Inc., the New York-based pharmaceutical company, has reportedly announced that its third-generation lung cancer drug LORBRENA has been approved by the U.S. Food & Drug Administration (FDA). Reports cite, the drug – an ALK TKI (Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor) – is designed …

Roche & Wellthy Therapeutics to introduce AI-based diabetes coaching

Leading drug firm Roche has reportedly formed a partnership with India’s Wellthy Therapeutics to provide its users with the Accu-Check Active system, an artificial intelligence-related digital diabetes coaching solution. As per trusted sources, the joint offering of the two companies will include the Accu-Check Active …

Cipla acquires USFDA approval for its hypertension, cardiac drug

Indian pharmaceutical and biotechnology conglomerate, Cipla Limited, has recently announced receiving a final approval for marketing its Metoprolol ER tablets from the United States Food and Drug Administration (USFDA). Sources close to the matter state that Cipla, at its recent BSE (Bombay Stock Exchange) filing, announced …